Sie befinden sich hier: Mitarbeiter > publist

Prof. Dr.med. Dr. h.c. Enno Christophers
Aktuelle Publikationen


2017

Keine Einträge

2016

Keine Einträge

2015

Griffiths CE, Christophers E, Szumski A, Jones H, Mallbris L
Impact of early vs. Late disease onset on treatment response to etanercept in patients with psoriasis.
Br. J. Dermatol. 2015;173:1271-1273
Augustin M, Radtke MA, Glaeske G, Reich K, Christophers E, Schaefer I, Jacobi A.
Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema.
Dermatology. 2015;231(1):35-40

2014

Breitbart EW, Christophers E.
Arbeitsgemeinschaft Dermatologische Prävention (ADP) e. V.
J Dtsch Dermatol Ges 2014;12 Suppl 4:42

2013

Christophers E, Segaert S, Milligan G, Molta CT, Boggs R.
Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study.
J Dermatolog Treat 2013;24(3):193-8

2012

Stockfleth E, Hinrichs B, Surber C, Christophers E.
Prevention initiative for dermatological malignancies: where do we stand?
Br J Dermatol 2012;167 Suppl 2:v-vi
Christophers E, Wenning J, Meurer M.
The Otto-Braun-Falco-Stipendium: A German-Polish success story
Hautarzt 2012;63 Suppl 1: 34-5
Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW.
Effectiveness of skin cancer screening programmes.
Br J Dermatol 2012;167 Suppl 2:94-8
Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, Schalkwijk J, Ståhle M, Burden AD, Smith CH, Cork MJ, Estivill X, Bowcock AM, Krueger GG, Weger W, Worthington J, Tazi-Ahnini R, Nestle FO, Hayday A, Hoffmann P, Winkelmann J, Wijmenga C, Langford C, Edkins S, Andrews R, Blackburn H, Strange A, Band G, Pearson RD, Vukcevic D, Spencer CC, Deloukas P, Mrowietz U, Schreiber S, Weidinger S, Koks S, Kingo K, Esko T, Metspalu A, Lim HW, Voorhees JJ, Weichenthal M, Wichmann HE, Chandran V, Rosen CF, Rahman P, Gladman DD, Griffiths CE, Reis A, Kere J; Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2, Nair RP, Franke A, Barker JN, Abecasis GR, Elder JT, Trembath RC.
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.
Nat Genet. 2012;44(12):1341-8

2011

Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation
Br J Dermatol 2011;164:586-92
Sticherling M, Augustin M, Boehncke WH, Christophers E, Domm S, Gollnick H, Reich K, Mrowietz U.
Therapy of psoriasis in childhood and adolescence - a German expert consensus.
J Dtsch Dermatol Ges. 2011;Epub ahead of print

2010

Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J.
Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased Eotaxin/CCL11 responsiveness to IL-4 stimulation.
Br J Dermatol. 2010;doi: 10.1111/j.1365-2133

2009

Dubertret L, Chimenti S, Christophers E, Daudén E, de Rie M, Griffiths CE, Kragballe K, Ståhle M, Stingl G.
Alice, Eloi, Magali and Robert: the lives of four patients with psoriasis and the therapeutic approaches of eight European experts.
Br J Dermatol 2009;161 Suppl 2: 1-30
Christophers E, Mrowietz U
Psoriasis
In: Burgdorf WHC, Plewig G, Wolhh HH, Landthaler M: Braun-Falcos Dermatology, 3. Aufl. 2009;

2008

Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R, Schreiber S, Kabelitz D, Lim HW, Voorhees JJ, Christophers E, Elder JT, Weichenthal M,
Polymorphism of the IL12B and IL23R genes are associated with psoriasis.
J Invest Dermatol 2008;128:1653-61
Christophers E.
The founding of the European Skin Research Foundation (ESRF)
J Dtsch Dermatol Ges. 2008;6(5):341
Christophers E.
Explaining phenotype heterogeneity in patients with psoriasis.
Br J Dermatol 2008;158(3):437-41

2007

Hügel R, Velasco P, De la Luz Sierra M, Christophers E, Schröder JM, Schwarz T, Tosato G, Lange-Asschenfeldt B
Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin
J Invest Dermatol 2007;127(1):65-74
Weichenthal M, Ruether A, Schreiber S, Nair R, Voorhees JJ, Schwarz T, Kabelitz D, Christophers E, Elder JT, Jenisch S.
Filaggrin R501X and 2282del4 mutations are not associated with chronic plaque-type psoriasis in a German cohort.
J Invest Dermatol. 2007;127(6): 1535-7
Christophers, E
Comorbidities in psoriasis
Clinic dermatol 2007;25(6):529-34
Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L
A classification of psoriasis vulgaris according to phenotype.
Br J Dermatol. 2007;156(2):258-62.
Christophers E
Comorbidities in psoriasis.
J Eur Acad Dermatol Venerol 2007;20:52-55
Christophers E
Defining psoriasis subtypes: features of severe psoriasis and associated diseases.
Expert Rev Dermatol 2007;2:1-5
Griffiths CE, Christophers E, Barker JN, Chalmers RJ, Chimenti S, Krueger GG, Leonardi C, Menter A, Ortonne JP, Fry L
A classification of psoriasis vulgaris according to phenotype.
Br J Dermatol 2007;156(2):258-62.
Christophers E
Psoriasis comorbidities reflect distinct mechanism of disease.
G Ital Dermatol Venerol 2007;142:513-158

2006

Fölster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Ruden U, Schrezenmeir J, Christophers E, Weichenthal M.
Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis.
Br J Dermatol. 2006;155(6):1256-61
Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M.
Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Arch Dermatol Res 2006;392:321-328
Nair RP, Stuart PE, Nistor I, Hiremagalore R, Chia NV, Jenisch S, Weichenthal M, Abecasis GR, Lim HW, Christophers E, Voorhees JJ, Elder JT.
Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene.
Am J Hum Genet 2006;78:827-851
Fölster-Holst R, Pape M, Buss YL, Christophers E, Weichenthal M.
Low prevalence of the intrinsic form of atopic dermatitis among adult patients.
Allergy 2006;61:629-632
Jenisch S, Hampe J, Elder JT, Nair R, Stuart P, Voorhees JJ, Schreiber S, Kabelitz D, Christophers E, Weichenthal M.
CARD15 mutations in patients with plaque-type psoriasis and psoriatic arthritis: lack of association.
Arch Dermatol Res 2006;297:409-411

2005

Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
NATURE IMMUNOLOGY 2005;6:57-64
Stuart P, Nair RP, Abecasis GR, Nistor I, Hiremagalore R, Chia NV, Qin ZS, Thompson RA, Jenisch S, Weichenthal M, Janiga J, Lim HW, Christophers E, Voorhees JJ, Elder JT
Analysis of RUNX1 Binding Site and RAPTOR Polymorphisms in Psoriasis: No Evidence for Association Despite Adequate Power and Evidence for Linkage
JOURNAL OF MEDICAL GENETICS 2005;42:500-502
Elder JT, Nair RP, Weichenthal M, Stuart P, Voorhees JJ, Christophers E, Jenisch S
The MHC Genes in Psoriasis
Current Genomics 2005;6:39-43
Elder JT, Abecasis G, Allen M, Barker JNWN, Burden D, Capon F, Christophers E, Fischer J, Giardina E, Gudjonsson JE, Hüffmeier U, Jenisch S, Karason A, Kere J, Nair RP, Sanchez F, Stahle M, Stuart P, Tillman D, Traupe H, Veal C, Voorhees JJ, Weichenthal
Fine Mapping of the Psoriasis Susceptibility Gene PSORS1: A Reassessment of Risk Associated with a Putative Risk Haplotype Lacking HLA-Cw6
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2005;124:921-930
Nistor I, Nair RP, Stuart P, Hiremagalore R, Thompson RA, Jenisch S, Weichenthal M, Abecasis GR, Qin ZS, Christophers E, Lim HW, Voorhees JJ, Elder JT
Protein tyrosine phosphatase gene PTPN22 polymorphism in psoriasis: lack of evidence for association.
JOURNAL OF INVESTIGATIVE DERMATOLOGY 2005;125:395-396
van de Kerkhof P, Griffiths CE, Christophers E, Lebwohl M, Krueger GG
Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
DERMATOLOGY 2005;211:256-263
Fölster-Holst R, Stoll M, Koch WA, Hampe J, Christophers E, Schreiber S.
Lack of association of SPINK5 polymorphisms with nonsyndromic atopic dermatitis in the population of Northern Germany.
BRITISH JOURNAL OF DERMATOLOGY 2005;152:1365-1367
Brandt O, Christophers E, Fölster-Holst R.
Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2005;52:101-104
Christophers, E, Mrowietz, U
Psoriasis
In: Braun-Falco et al., Dermatologie und Venerologie, Springer-Verlag, Heidelberg, 5. Auflage 2005;
Christophers, E., Mrowietz, U.
Psoriasis.
In: Braun-Falco et al., Dermatologie und Venerologie, Springer-Verlag, Heidelberg, 5. Auflage. 2005;

2004

Folster-Holst R, Weichenthal M, Steinsland K, Polzhofer G, Christophers E
Eczema infantum and its prognosis
ACTA DERMATO-VENEREOLOGICA 2004;84:410-412
Stockfleth E, Christophers E, Benninghoff B, Sterry W
Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study
ARCHIVES OF DERMATOLOGY 2004;140:1542-1543
Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M, Ferrandiz C, Griffiths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K, Prinz J, Rzany B, Ronnevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhof P, Voorhees J
Biological therapies in the systemic management of psoriasis: International Consensus
BRITISH JOURNAL OF DERMATOLOGY 2004;69:3-17

2003

Schmook T, Stockfleth E, Lischner S, Gahn B, Christophers E, Hauschild A
Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP).
CLINICAL AND EXPERIMENTAL DERMATOLOGY  2003;28:31-33
Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, Lamarque V, Dubertret L
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.
JOURNAL OF INVESTIGATIVE DERMATOLOGY  2003;120:211-216
Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis
ARCHIVES OF DERMATOLOGY  2003;139:719-727
Meyer T, Arndt R, Nindl I, Ulrich C, Christophers E, Stockfleth E
Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients.
TRANSPLANT INTERNATIONAL  2003;16:146-153
Dunsche A, Kastel I, Terheyden H, Springer IN, Christophers E and Brasch J
Oral lichenoid reactions associated with amalgam: improvement after amalgam removal
BRITISH JOURNAL OF DERMATOLOGY  2003;148:70-76
Brasch J, Kreiselmaier I and Christophers E
Inhibition of dermatophytes by optical brighteners.
MYCOSES 2003;46:120-125
Ghoreschi K, Thomas P, Breit S, Dugas M, Mailhammer R, van Eden W, van der Zee R, Biedermann T, Prinz J, Mack M, Mrowietz U, Christophers E, Schlondorff D, Plewig G, Sander CA AND Röcken M
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
NATURE MEDICINE  2003;9:40-46
Christophers E
Targeting T-cell subsets to achieve remission.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY  2003;17 Suppl. 2: 6-11
Hauschild A, Christophers E
Melanom.
In: Onkologische Therapie. Hrsg.: Bruhn D, Fölsch UR, Kneba M, Löffler H. Schattauer, Stuttgart. 2003;
Christophers, E., Mrowietz, U.
Pustular eruptions of palms and soles.
In: Freedberg I.M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. I. (Editors), Dermatology in general medicine, 6th edition 2003, Mc Graw-Hill, New York. 2003;
Christophers E, Mrowietz U
Psoriasis.
In: Freedberg I.M., Eisen, A. Z., Wolff, K., Austen, K. F., Goldsmith, L. A., Katz, S. I. (Editors), Dermatology in general medicine, 6th edition 2003, Mc Graw-Hill, New York. 2003;

2002

Chuong, C.M., Nickoloff, B.J., Elias, P.M., Goldsmith, L.A., Macher, E., Maderson, P.A., Sundberg, J.P., Tagami, H., Plonka, P.M., Thestrup-Pederson, K., Bernard, B.A., Schroder, J.M., Dotto, P., Chang, C.M., Williams, M.L., Feingold, K.R., King, L.E., Kligman, A.M., Rees, J.L., Christophers, E.
What is the 'true' function of skin?
EXPERIMENTAL DERMATOLOGY  2002;11:159-187
Eiling, S., Lischner, S., Rosien, F., Haacke, T.C., Schafer, F., Christophers, E., Hauschild, A.
Temozolomid als Therapieoption bei fernmetastasierten Melanompatienten mit ungünstiger Prognose.
HAUTARZT 2002;53:659-665
Gollnick, H., Altmeyer, P., Kaufmann, R., Ring, J., Christophers, E., Pavel, S., Ziegler, J.
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris.
DERMATOLOGY 2002;205:46-53
Guo, S.W., Jenisch, S., Stuart, P., Lange, E.M., Kukuruga, D., Nair, R., Henseler, T., Voorhees, J., Christophers, E., Elder, J.T.
Combined segregation and linkage analysis of HLA markers in familial psoriasis.
EUROPEAN JOURNAL OF HUMAN GENETICS 2002;10:327-333
Kromminga, A., Sitaru, C., Meyer, J., Arndt, R., Schmidt, E., Christophers, E., Brocker, E.B., Zillikens, D.
Cicatricial pemphigoid differs from bullous pemphigoid and pemphigoid gestationis regarding the fine specificity of autoantibodies to the BP180 NC16A domain.
JOURNAL OF DERMATOLOGICAL SCIENCE  2002;28:68-75
Meyer, T., Hauschild, A., Kromminga, A., Hartlepp, J., Arndt, R., Christophers, E., Stockfleth, E.
Clinical evaluation of 5-S-Cysteinyldopa testing using a new and optimized detection system as a tumour marker for malignant melanoma.
MELANOMA RESEARCH 2002;12:471-477
Orfanos, C.E., Christophers, E.
From dermatology into cosmetics. Chance or risk?
HAUTARZT 2002;53:1-4
Steude, J., Kulke, R., Christophers, E.
The role of the Duffy antigen-related chemokine receptor in psoriasis vulgaris.
CYTOKINE 2002;18:329-333
Stockfleth, E., Meyer, T., Benninghoff, B., Salasche, S., Papadopoulos, L., Ulrich, C., Christophers, E.
A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.
ARCHIVES OF DERMATOLOGY 2002;138:1498-1502
Stockfleth, E., Ulrich, C., Hauschild, A., Lischner, S, Meyer, T., Christophers, E.
Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. A report of 3 cases.
EUROPEAN JOURNAL OF DERMATOLOGY 2002;12:569-572
Stockfleth, E., Ulrich, C., Meyer, T., Christophers, E.
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.
Recent Results Cancer Res 2002;62:2004-2012
Stuart, P., Malick, F., Nair, R.P., Henseler, T., Lim, H.W., Jenisch, S., Voorhees, J., Christophers, E., Elder, J.T.
Analysis of phenotypic variation in psoriasis as a function of age at onset and family history.
ARCHIVES OF DERMATOLOGICAL RESEARCH 2002;294:207-213
Thaci, D., Brautigam, M., Kaufmann, R., Weidinger, G., Paul, C., Christophers, E.
Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised study.
DERMATOLOGY 2002;205:383-388
Ulrich, C., Christophers, E., Sterry, W., Meyer, T., Stockfleth, E.
Skin diseases in organ transplant patients.
HAUTARZT 2002;53:524-533
Foelster-Holst, R., Henseler, T., Wehde, J., Lemke, H., Weichenthal, M., Christophers, E., Hansen, H.P.
Soluble CD30 plasma concentrations correlate with disease activity in patients with atopic dermatitis.
ACTA DERMATO-VENEREOLOGICA 2002;82:245-248
Eiling, S., Lischner, S., Busch, J.O., Rothaupt, D., Christophers, E., Hauschild, A.
Complete remission of a radio-resistant cutaneous angiosarcoma of the scalp by systemic treatment with liposomal doxorubicin.
BRITISH JOURNAL OF DERMATOLOGY 2002;147:150-153
Frick S, Lischner S, Rosien F, Haacke TC, Schafer F, Christophers E, Hauschild A
Temozolomid als Therapieoption bei Patienten mit fernmetastasiertem Melanom und ungünstiger Prognose
Hautarzt 2002;53(10):659-65

Zurück

Aktuelles:

 

Praktikum der Dermatologie

Das Hauptpraktikum Dermatologie beginnt am 17.10.2017 um 7:45 mit einer Einführungsvorlesung im Hörsaal der Hautklinik.  [mehr]

 


Dermatologie für Zahnmediziner

Die Veranstaltung beginnt am 24.10.2017  um 10:00 c.t. im Hörsaal der Hautklinik.


Lehrpreis 2017

Der Preis der Medizinischen Fakultät für die beste Lehre geht in diesem Jahr erneut an die Hautklinik  [mehr]


Neurodermitis Präventionsstudie

Studie zur frühkindlichen Anwendung von Hautpflegecremes [mehr]


Regulation von Botenstoffen der Entzündung

Kieler Team des Exzellenzclusters Entzündungsforschung deckt grundlegend neuen Mechanismus au. [mehr]


Prof. Fölster-Holst neue Präsidentin der ESPD

Professorin Dr. Regina Fölster-Holst, Klinik für Dermatologie, Venerologie und Allergologie, Medizinische Fakultät der Christian-Albrechts-Universität zu Kiel ist neue Präsidentin der Europäischen Gesellschaft für Kinderdermatologie (European Society for Pediatric Dermatology, ESPD). [mehr]


Patientenleitlinie zum Melanom erschienen

Der umfangreiche Ratgeber gibt in allgemeinverständlicher Sprache alle Empfehlungen zu Untersuchungen und Behandlungen wieder, die zuvor für die ärztliche Leitlinie zum Melanom erarbeitet worden sind.

Die Druckfassung zum kostenlosen Download [hier]   

 

Die Seite wurde zuletzt am 16.11.2017 um 11:51 geändert.